The average expenditure of pharmaceutical companies on research and development has increased four times in the last five years.
A 15 per cent corporate tax rate for services companies in SEZs, setting up a fund for deep-tech startups and establishing clusters to demonstrate design-to-manufacturing capabilities of tech firms were some of the key demands made by the IT sector at the pre-Budget consultation on Monday. The participants shared their views and suggestions regarding Big Data, incentives for encouraging setting up of data centres, fiscal incentives for data localisation, incentives for pushing digital penetration in rural areas, and corporate guarantee to startups for competing with other nations.
The Central Bureau of Investigation has registered a corruption case against unknown officials of the Cabinet Secretariat, a specialised covert unit of Research and Analysis Wing and private businessmen for alleged irregularities in the purchase of tents worth Rs 22 crore, official sources said in New Delhi.
The Hyderabad centre will be a software R&D facility of the company in India that works on different components of software products being designed by Quantum to integrate them with data storage and protection systems.
Intas Biopharmaceuticals Ltd (IBPL) plans to generate clones for commercial production of protein. The company has finalised a Research and Development (R&D) agreement for the development and production of therapeutic protein with Viropro International Inc, a subsidiary of Viropro Inc
Three IIT-M students have developed a smart air purifier that removes dust, pollen, pet dander, particulates and pollutants that cause us the most harm, like mould, viruses, bacteria and gaseous chemicals.
The Brezza is Maruti's answer to the Ford EcoSport and Mahindra TUV300 and was developed in India at a cost of Rs 860 crore.
TVS Motors is exploring LPG and CNG enabled two wheelers. It is also ready to launch electric scooters.
Hyundai Motor India Limited is taking the adage -- what cannot be measured cannot be controlled -- very seriously. In a move to control costs, it is implementing an innovative plan where the car-marker has incentivised every small idea to reduce the weight of the car it makes by offering Rs 100 for every gram saved in weight.
The alternative fuel fever has caught up with Chennai-based TVS Motor Company, synonymous with 'TVS Scooty'. Having entered the electric scooter segment, the company is exploring LPG and CNG two wheelers.
Since Malvinder Mohan Singh announced last week that he would sell leading Indian generic drug maker Ranbaxy to Daiichi Sankyo of Japan, incredulous friends have deluged him with messages.
The PhRMA's observation is significant against the backdrop of Swiss pharma major Novartis AG's decision to relocate its R&D investments from India.
Rajnath also pitched for incentives in defence manufacturing, Singh said foreign companies are not only interested in investing in India but also ready to transfer technologies.
Under the next phase of missile development programme, the DRDO was working on Long Range Surface-to-air Missiles (LR SAM), which have a range of 70 km, with international collaboration, Prahlada said but declined to name the countries with whom the joint research will be done.
Sun Pharmaceutical Industries will take a call on whether to shut Ranbaxy's troubled factories or make changes in the top management of the latter only after its $4-billion acquisition deal is complete.
